Teradyne (NASDAQ:TER) Reports Q1 In Line With Expectations But Next Quarter’s Sales on TrackSemiconductor testing company Teradyne (
NASDAQ:TER) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.3% year on year to $685.7 million. The company expects next quarter’s revenue to be around $645 million, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 21.8% above analysts’ consensus estimates.
Waste Management (NYSE:WM) Misses Q1 Revenue EstimatesWaste management services provider Waste Management (
NYSE:WM) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 16.7% year on year to $6.02 billion. Its non-GAAP profit of $1.67 per share was 5.2% above analysts’ consensus estimates.
UFP Industries (NASDAQ:UFPI) Reports Sales Below Analyst Estimates In Q1 EarningsBuilding materials manufacturer UFP Industries (
NASDAQ:UFPI) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 2.7% year on year to $1.60 billion. Its GAAP profit of $1.30 per share was 16.9% below analysts’ consensus estimates.
Amkor (NASDAQ:AMKR) Beats Expectations in Strong Q1, Guides for Strong Sales Next QuarterSemiconductor packaging and testing company Amkor Technology (
NASDAQ:AMKR) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.2% year on year to $1.32 billion. On top of that, next quarter’s revenue guidance ($1.43 billion at the midpoint) was surprisingly good and 5.6% above what analysts were expecting. Its GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
Crane’s (NYSE:CR) Q1 Sales Top EstimatesIndustrial conglomerate Crane (
NYSE:CR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $557.6 million. Its non-GAAP profit of $1.39 per share was 6.5% above analysts’ consensus estimates.
NXP Semiconductors (NASDAQ:NXPI) Reports Q1 In Line With Expectations But Stock DropsChip manufacturer NXP Semiconductors (
NASDAQ: NXPI) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 9.3% year on year to $2.84 billion. The company expects next quarter’s revenue to be around $2.9 billion, coming in 1.1% above analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.4% above analysts’ consensus estimates.
Universal Health Services (NYSE:UHS) Misses Q1 Sales TargetsHospital management company Universal Health Services (
NYSE:UHS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 6.7% year on year to $4.1 billion. Its GAAP profit of $4.80 per share was 8.9% above analysts’ consensus estimates.
Medifast (NYSE:MED) Misses Q1 Sales TargetsWellness company Medifast (
NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.
Cadence’s (NASDAQ:CDNS) Q1 Earnings Results: Revenue In Line With ExpectationsSemiconductor design software provider Cadence Design Systems (
NASDAQ:CDNS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.1% year on year to $1.24 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.19 billion at the midpoint. Its GAAP profit of $1 per share was 1.9% above analysts’ consensus estimates.
Simpson’s (NYSE:SSD) Q1 Sales Beat EstimatesBuilding products manufacturer Simpson (
NYSE:SSD) announced better-than-expected revenue in Q1 CY2025, with sales up 1.6% year on year to $538.9 million. Its GAAP profit of $1.85 per share was 18.1% above analysts’ consensus estimates.
F5 (NASDAQ:FFIV) Beats Q1 Sales Targets, Provides Encouraging Quarterly Revenue GuidanceNetwork application delivery and security specialist F5 (
NASDAQ:FFIV) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.3% year on year to $731.1 million. Guidance for next quarter’s revenue was better than expected at $750 million at the midpoint, 1.6% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 10.1% above analysts’ consensus estimates.
Leggett & Platt’s (NYSE:LEG) Q1 Earnings Results: Revenue In Line With Expectations, Stock Jumps 13.1%Manufacturing company Leggett & Platt (
NYSE:LEG) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.8% year on year to $1.02 billion. On the other hand, the company’s full-year revenue guidance of $4.15 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.24 per share was 10.3% above analysts’ consensus estimates.
Kforce (NYSE:KFRC) Misses Q1 Sales TargetsProfessional staffing firm Kforce (
NYSE:KFRC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.2% year on year to $330 million. Next quarter’s revenue guidance of $336 million underwhelmed, coming in 2% below analysts’ estimates. Its GAAP profit of $0.45 per share was 3.3% below analysts’ consensus estimates.
Crown Holdings’s (NYSE:CCK) Q1 Sales Top EstimatesMetal packaging products manufacturer Crown Holdings (
NYSE:CCK) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 3.7% year on year to $2.89 billion. Its non-GAAP profit of $1.67 per share was 35.7% above analysts’ consensus estimates.
Woodward (NASDAQ:WWD) Reports Bullish Q1, Full-Year Outlook Slightly Exceeds ExpectationsAerospace and defense company Woodward (
NASDAQ:WWD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.8% year on year to $883.6 million. The company’s full-year revenue guidance of $3.44 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $1.69 per share was 15.4% above analysts’ consensus estimates.
Sanmina (NASDAQ:SANM) Posts Better-Than-Expected Sales In Q1 But Quarterly Revenue Guidance Misses ExpectationsElectronics manufacturing services company Sanmina (
NASDAQ:SANM) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.1% year on year to $1.98 billion. On the other hand, next quarter’s revenue guidance of $1.98 billion was less impressive, coming in 4.4% below analysts’ estimates. Its non-GAAP profit of $1.41 per share was 2.5% above analysts’ consensus estimates.
Why Is Peloton (PTON) Stock Rocketing Higher TodayShares of exercise equipment company Peloton (
NASDAQ:PTON)
jumped 6.4% in the pre-market session after Truist analysts upgraded the stock's rating from Hold to Buy, signaling renewed confidence in the company's turnaround efforts. In their note, the firm emphasized that more than three years after initially downgrading Peloton, they saw tangible improvements in the company's fundamentals.
Why Sabre (SABR) Stock Is Up TodayShares of travel technology company Sabre (
NASDAQ:SABR)
jumped 21.1% in the morning session after the company agreed to sell its hospitality solutions business to TPG for $1.1 billion. The proceeds from the sale were expected to significantly bolster SABR's cash reserves, giving it more flexibility to invest in growth areas such as its airline IT services and travel marketplace platforms. Additionally, the transaction supported the company's efforts to achieve its target leverage ratio of 2.5x to 3.5x, which could improve its appeal to investors.
Why Plug Power (PLUG) Stock Is Up TodayShares of fuel cell technology Plug Power (
NASDAQ:PLUG) jumped 39.2% in the morning session after the company locked in a new loan of up to $525 million, boosting its cash pile and providing more headroom to support operations and future growth plans. It also shared strong early sales for the first quarter of 2025, beating Wall Street's estimates. Q1 2025 revenue guidance was estimated at around $130 million to $134 million.
1 Mid-Cap Stock with Exciting Potential and 2 to Turn DownMid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
3 Cash-Heavy Stocks in the DoghouseA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
3 Consumer Stocks with Questionable FundamentalsRetailers are evolving to meet the expectations of modern, tech-savvy shoppers. But many seem to be moving too slowly as their demand is lagging, causing the industry to underperform the market -
over the past six months, retail stocks have shed 13.6%. This drawdown was worse than the S&P 500’s 5.1% loss.
2 Cash-Heavy Stocks to Keep an Eye On and 1 to Brush OffCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear OfWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
1 Oversold Stock Ready to Bounce Back and 2 to Keep Off Your RadarRock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
2 Mid-Cap Stocks Worth Your Attention and 1 to Steer Clear OfMid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
3 Cash-Heavy Stocks That Concern UsA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
1 Profitable Stock to Research Further and 2 to IgnoreNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Volatile Stocks with Questionable FundamentalsA highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
1 Profitable Stock to Target This Week and 2 to QuestionWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Market-Beating Stocks for Long-Term InvestorsStocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
2 Profitable Stocks on Our Buy List and 1 to Think Twice AboutA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
1 Cash-Producing Stock Worth Your Attention and 2 to Think Twice AboutA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Hated Stocks in the DoghouseHitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
3 Profitable Stocks in Hot WaterNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Dawdling Stocks with Mounting ChallengesStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
3 Dawdling Stocks Facing HeadwindsStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
1 Profitable Stock to Target This Week and 2 to Approach with CautionWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Cash-Heavy Stocks Skating on Thin IceA cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
1 Profitable Stock on Our Watchlist and 2 to Be Wary OfA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Profitable Stocks with Mounting ChallengesWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Dawdling Stocks Walking a Fine LineA stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
1 Healthcare Stock Worth Your Attention and 2 to Turn DownPersonal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 11.7%. This performance was worse than the S&P 500’s 5.1% loss.
2 Unprofitable Stocks to Research Further and 1 to QuestionUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
2 Profitable Stocks with Solid Fundamentals and 1 to Approach with CautionA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Cash-Producing Stocks Walking a Fine LineA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 Hated Stock that Deserves Some Love and 2 to IgnoreWall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
3 Cash-Producing Stocks in the DoghouseA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Unprofitable Stocks with Questionable FundamentalsUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
3 Market-Beating Stocks with Solid FundamentalsStocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 to IgnoreThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Be Wary OfThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 Cash-Producing Stock to Own for Decades and 2 to Approach with CautionWhile strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 to Brush OffWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
3 Value Stocks That Concern UsValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
3 Healthcare Stocks That Concern UsFrom novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 11.7%. This drawdown was worse than the S&P 500’s 5.2% decline.
2 Hated Stocks that Deserve a Second Chance and 1 to Think Twice AboutWall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
1 Volatile Stock to Target This Week and 2 to Keep Off Your RadarVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
1 Volatile Stock to Own for Decades and 2 to Keep Off Your RadarMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
3 Value Stocks Facing HeadwindsThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 of Wall Street’s Favorite Stocks Skating on Thin IceWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Domino's (NASDAQ:DPZ) Misses Q1 Sales TargetsFast-food pizza chain Domino’s (
NYSE:DPZ) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.5% year on year to $1.11 billion. Its GAAP profit of $4.33 per share was 6.3% above analysts’ consensus estimates.
Revvity (NYSE:RVTY) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds ExpectationsLife sciences company Revvity (
NYSE:RVTY) announced better-than-expected revenue in Q1 CY2025, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 6.4% above analysts’ consensus estimates.
TransDigm (TDG): 3 Reasons We Love This StockTransDigm currently trades at $1,377 per share and has shown little upside over the past six months, posting a middling return of 2.8%. However, the stock is beating the S&P 500’s 5.4% decline during that period.
3 Reasons to Avoid PTLO and 1 Stock to Buy InsteadPortillo’s stock price has taken a beating over the past six months, shedding 20.5% of its value and falling to $10.59 per share. This might have investors contemplating their next move.
3 Reasons ACEL is Risky and 1 Stock to Buy InsteadAccel Entertainment trades at $10.28 per share and has stayed right on track with the overall market, losing 9.5% over the last six months while the S&P 500 is down 5.4%. This may have investors wondering how to approach the situation.
3 Reasons COHR is Risky and 1 Stock to Buy InsteadCoherent has gotten torched over the last six months - since October 2024, its stock price has dropped 33.4% to $64.20 per share. This might have investors contemplating their next move.
2 Reasons to Like ERII (and 1 Not So Much)Over the past six months, Energy Recovery’s shares (currently trading at $15.02) have posted a disappointing 16.5% loss while the S&P 500 was down 5.3%. This may have investors wondering how to approach the situation.
3 Reasons to Sell TDUP and 1 Stock to Buy InsteadThredUp has been on fire lately. In the past six months alone, the company’s stock price has rocketed 489%, reaching $4.20 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid QLYS and 1 Stock to Buy InsteadSince October 2024, Qualys has been in a holding pattern, posting a small return of 2.8% while floating around $125.31. However, the stock is beating the S&P 500’s 5.3% decline during that period.
3 Big Reasons to Love Semrush (SEMR)Semrush’s stock price has taken a beating over the past six months, shedding 20.1% of its value and falling to $10.33 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Braze (BRZE): Buy, Sell, or Hold Post Q4 Earnings?Since October 2024, Braze has been in a holding pattern, floating around $30.70.
3 Reasons KMT is Risky and 1 Stock to Buy InsteadKennametal’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $19.29 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Q4 Earnings Roundup: BlackLine (NASDAQ:BL) And The Rest Of The Finance and HR Software SegmentEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BlackLine (
NASDAQ:BL) and its peers.
Fastenal (FAST): Buy, Sell, or Hold Post Q1 Earnings?While the broader market has struggled with the S&P 500 down 5.3% since October 2024, Fastenal has surged ahead as its stock price has climbed by 6% to $81.29 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
